Yahoo Web Search

Search results

1. • 

     When depression meds don’t work, this may help you turn the corner

     UC Newsroom· 1 hour ago

     Awareness Month in May, we talk to psychiatrist Katherine Scangos, M.D., Ph.D., co-director of the...

2. • 

     Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters

     Investing.com· 6 days ago

     The data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...

3. • 

     Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows

     Colorado Springs Gazette· 6 days ago

     The data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...

4. • 

     Short-Term Market Volatility Could Provide Long-Term Investing Opportunities

     Morningstar· 6 days ago

     Why Morningstar thinks Apple could turn it around for 2025. Plus, the Federal Reserve is delaying...

5. • 

     Kelly Clarkson Talks Losing ‘A Lot’ of Weight on Prescription Medication: ‘Everybody Thinks It’s...

     Billboard via Yahoo News· 2 days ago

     Clarkson said the unnamed drug she’s taking “aids in helping break down the sugar [because]...

6. • 

     Kaiser Permanente vs. Anthem: Medicare Advantage Comparison - NerdWallet

     Nerdwallet· 2 days ago

     Kaiser Permanente’s star ratings are higher, while Anthem's member experience scores are better....

7. • JD Supra: The Focus of Federal Proposals on Pharmacy Benefit Management – 118th Congress

     JD Supra· 20 hours ago

     Over the past several years, legislators across the country have focused their attention on Pharmacy Benefit Managers (PBMs) due to concerns expressed over a variety of industry...

8. • 

     Aetna vs. Anthem: Medicare Advantage Comparison - NerdWallet

     Nerdwallet· 2 days ago

     Aetna offers Medicare Advantage plans in more states and covers nearly twice as many members as...

9. • Q3 2024 Aytu Biopharma Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 4 hours ago

     We're solving this issue and our results speak to that. And as we look at prescription trends in April and into May, we're seeing growth in Rxs for the ADHD brands. In fact ...

10. • 

      Despite Lower Out-Of-Pocket Costs, Insulin Affordability Is Still A Critical Issue

      Forbes· 5 days ago

      In describing the financial burden caused by the high price of insulin products, a Fortune article...